Delivery Order SPE2DB22D3016-SPE2DB25FBKQ4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,470.98 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract portfolio and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $6,052.44. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $9,909.80 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/ml vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a $3,488 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $3,106.84. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 5, 2025, with the place of performance located in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical vendor for federal medical procurement, specifically supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Phenobarbital 130 mg/mL vials under a firm fixed-price contract. This award, valued at $1,287.42, represents a competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,133.18. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.09 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials, with an ultimate completion date of July 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.75 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This firm fixed-price, competitively awarded contract contains no set-aside designation and is scheduled for completion by July 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement supporting federal...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKQ4Delivery Order
The Defense Logistics Agency awarded a $6,483.54 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vial on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This pharmaceutical supply contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical supplier to the federal government's military and veteran healthcare systems. The company's substantial IDC with DLA encompasses a broad portfolio of pharmaceutical products and medical supplies supporting Defense Health Agency and other federal healthcare customers globally. This particular delivery order for phenobarbital represents a routine fulfillment under the broader pharmaceutical prime vendor agreement, providing essential neurological medication to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/23/25 |